Drug major Sun Pharmaceutical Industries on Friday reported a consolidated net profit of Rs 1,444.17 crore for the June 2021 quarter, mainly on account of robust sales across markets. The company had ...

Drug major Sun Pharmaceutical Industries on Thursday reported an over two-fold jump in consolidated net profit at Rs 894.15 crore for the quarter ended March 2021, mainly on account of a robust perfor...

Sun Pharmaceutical Industries Ltd and its founder Dilip Shanghvi have settled a whistleblower complaint with the Securities and Exchange Board of India (Sebi) alleging diversion of funds through the c...

...

The shares of Sun Pharmaceutical Industries ended lower on the bourses on Monday after the company said that the US drug regulator may not give the green signal for the export of new products from its...

Shares of Sun Pharmaceutical Industries rallied over 8 per cent a day after the company informed that its board will be meeting next week to discuss a proposal for buyback of shares.On the BSE, the Su...

Dilip Shanghvi, the founder and managing director of Sun Pharmaceutical Industries, on Monday indicated the company was open to taking a relook at some of the earlier transactions or decisions in the ...

Drug major Sun Pharmaceutical Industries on Tuesday said its board has approved a Rs 1,700-crore share buyback offer at a maximum price of Rs 425 per share.The board of directors, at its meeting held ...